Scout | Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R21 Clinical Trial Not Allowed)

This grant supports research on how autophagy-related cell death and HIV development interact, specifically focusing on how the brain's immune responses are affected by both short-term and long-term drug use.

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Opportunity Released: December 6, 2023

Open for Submission: December 6, 2023

Submission Deadline: November 14, 2024

Application Window Closes: November 14, 2024

Keywords

autophagy

cell death

HIV pathogenesis

CNS immune response

drug use

acute drug use

chronic drug use

funding opportunity

research grant

immunology

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers